Table 2 Proportions of patients eligible for guideline-based therapies by categories of estimated glomerular filtration rate.
Treatment | GFR ≥ 90 (n = 626) | GFR 60- < 90 (n = 1073) | GFR 30- < 60 (n = 530) | GFR < 30 (n = 197) | p (trend) |
|---|---|---|---|---|---|
Acute aspirin | 99.0% | 98.5% | 97.9% | 98.0% | 0.114 |
Acute beta blocker | 93.6% | 95.6% | 93.4% | 92.9% | 0.531 |
Discharge aspirin | 98.4% | 97.6% | 96.2% | 94.4% | 0.001 |
Discharge beta blocker | 94.6% | 96.0% | 96.2% | 95.9% | 0.220 |
Discharge ACE/ARB | 22.5% | 20.1% | 29.1% | 27.4% | 0.006 |
Discharge Statin | 97.4% | 97.3% | 95.7% | 95.9% | 0.073 |